Genetics of Cortisol-Producing Adrenal Adenomas: Adrenal adenomas have been demonstrated to arise from the same types of genetic mutations we have discussed in articles on adrenal hyperplasia. Most of these are likely somatic mutations leading to a single nodule rather than hyperplasia. It is not necesssry to test for these mutations in affected patients. There is no increased risk of developing adenomas in first degree relatives.
Micronodular Adrenal Hyperplasia: I consider micronodular caused is hyperplasia to be characterized by nodules less that 1 cm in diameter. There are two caveats. First, some patients may evolve to macronodular hyperplasia if they have simply been diagnosed early. Second, some with primary pigmented nodular adrenocortical disease rarely may have nodules larger than 1cm.
PPNAD is most often associated with Carney Complex and is due to inactivating mutations in the PRKAR1A gene . These mutations cause excess protein kinase A signaling and dysregulated cell growth and division. Isolated PPNAD has also been described. Mutations of the PDE11A and PDE8B also cause isolated PPNAD. The mutations in the isolated and Carney complex forms of PPNAD are autosomal dominant in transmission. We have reviewed PPNAD in detail elsewhere on Adrenal World News.
Most of the hyperplasias associated with PPNAD have pigmentation in the adrenal glands. There is atrophy of the tissues between the nodules of hyperactive tissue. The next types of micronodular hyperplasia and the macronodular hyperplasias typically have hyperplastic changes in the adrenal tissues between the larger nodules.
A few more important facts:
- Activating somatic mutations in the PRKACA gene also cause micronodular hyperplasia.
- McCune-Albright syndrome due to GNAS mutations can cause micronodular adrenal hyperplasia and hypercortisolism in children.
- Diagnosis and treatment for these conditions is reviewed in our companion article on macronodular adrenal hyperplasia.
Macronodular Adrenal Hyperplasia: This condition is characterized by bilateral adrenal enlargement. The adrenals usually contain several nodules varying in size with some greater than 1 cm in diameter. Some of my patients have had nodules more than 3 cm in diameter. Some patients may have micronodular disease when they are diagnosed. This condition is most common in middle-aged and older adults.
Cushing’s syndrome due to hypercortisolism or disorders such as hypertension, diabetes mellitus, and osteoporosis in the setting of mild autonomous cortisol secretion (MACS) are commonly seen in affected patients. This condition is, basically, one in which the adrenal glands become cortisol factories on autopilot. The high cortisol levels suppress ACTH levels. DHEA-S levels are usually low. Most patients fail to suppress serum cortisol during the overnight 1 mg and high dose 8 mg dexamethasone suppression tests. Patients with advanced disease and marked cortisol excess typically have elevated late night salivary cortisol levels.
Two common gene mutations can cause this syndrome. About half of patients have a mutation in the ARMC5 gene. This mutation impairs the function of the protein the gene regulates that would normally suppress hyperplasia in the adrenals. This mutation is inherited. Having one copy of the mutation only leads to disease when adrenal cells acquire a mutation in the other copy of the gene on the normal chromosome. Fifty percent of first degree relatives of affected patients are at risk to have inherited the one copy of the mutation. Another mutation is in the GNAS gene. The mutation results in overactivity of a G-protein that stimulates cyclic AMP production that, in turn, causes abnormal cell growth. This mutation is not inherited. It happens during early development of the embryo.
We will discuss the genetics and pathophysiology of food-dependent Cushing’s syndrome and macronodular hyperplasia in a separate article.
Treatment decisions are usually individualized. Bilateral adrenalectomy is often required. Unilateral adrenal every may be a useful measure to control hypercortisolism. A few centers are experimenting with subtotal adrenalectomy to preserve some adrenal function. These patients, even if cortisol productions rates are normal will still have MACS. In my opinion, anything less that total bilateral adrenalectomy may result in only temporary benefits. Drugs that inhibit cortisol production or that modulate the activity of the glucocorticoid receptor may also be used when patients either decline or are not candidates for adrenalectomy.
© 2026, J D Faccinetti. All rights reserved.